← Back to Search

Diagnostic Test

LINFU™ for Pancreatic Adenocarcinoma

N/A
Waitlist Available
Led By Scott Corbett, MD, FASGE
Research Sponsored by Adenocyte, LLC
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 4 months
Awards & highlights
No Placebo-Only Group

Summary

This trial uses the LINFU™ Technique, which employs ultrasound and a special dye to collect pancreatic fluid. It targets people at high risk for pancreatic cancer. The method involves stimulating the pancreas to release fluid, which is then collected and analyzed.

Eligible Conditions
  • Pancreatic Adenocarcinoma
  • Dysplasia

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~4 months
This trial's timeline: 3 weeks for screening, Varies for treatment, and 4 months for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Does LINFU™ yield an adequate number of cells that can be used to help diagnose pancreatic precancers and cancers?

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

1Treatment groups
Experimental Treatment
Group I: The LINFU™ testExperimental Treatment1 Intervention
LINFU™ to increase sensitivity of pancreatic juice cytology LINFU™ consists of analysis of pancreatic fluid collected with the help of low intensity non-focused ultrasound excitation of the pancreas. Lumason, will be used to create bubbles and possibly increase the number of pancreatic cell we collect for the study. Secretin is also used to increase the number of pancreatic cell excretion to maximize the number of cells collected.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
LINFU™
2021
N/A
~20

Find a Location

Who is running the clinical trial?

Adenocyte, LLCLead Sponsor
5 Previous Clinical Trials
3,500 Total Patients Enrolled
Scott Corbett, MD, FASGEPrincipal InvestigatorSuncoast Endoscopy of Sarasota (a division of Florida Digestive Health Specialists)
~3 spots leftby Nov 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top